Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2018 - Product Image

Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2018

  • ID: 4544601
  • Report
  • 104 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AIS Inc.
  • Boston Scientific Corp
  • CardiaLen Inc.
  • InnerPulse Inc
  • Johns Hopkins University
  • Kenergy Inc.
  • MORE
Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2018

Summary

The author's Medical Devices sector report, “Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2018" provides an overview of Implantable Cardioverter Defibrillators (ICD) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Implantable Cardioverter Defibrillators (ICD) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Implantable Cardioverter Defibrillators (ICD) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Implantable Cardioverter Defibrillators (ICD) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry.
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Implantable Cardioverter Defibrillators (ICD) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AIS Inc.
  • Boston Scientific Corp
  • CardiaLen Inc.
  • InnerPulse Inc
  • Johns Hopkins University
  • Kenergy Inc.
  • MORE
1 Table of Contents

2 Introduction
2.1 Implantable Cardioverter Defibrillators (ICD) Overview

3 Products under Development
3.1 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
3.2 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment
3.3 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory
3.4 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path
3.5 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date
3.6 Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials

4 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products under Development by Companies
4.1 Implantable Cardioverter Defibrillators (ICD) Companies - Pipeline Products by Stage of Development
4.2 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development

5 Implantable Cardioverter Defibrillators (ICD) Companies and Product Overview
5.1 AIS Inc. Company Overview
5.1.1 AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.2 Boston Scientific Corp Company Overview
5.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.3 CardiaLen, Inc. Company Overview
5.3.1 CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.4 InnerPulse Inc (Inactive) Company Overview
5.4.1 InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.5 Johns Hopkins University Company Overview
5.5.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.6 Kenergy Inc. Company Overview
5.6.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.7 LivaNova PLC Company Overview
5.7.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
5.8 Massachusetts General Hospital Company Overview
5.8.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.9 Max Planck Institute for Dynamics and Self-Organization Company Overview
5.9.1 Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview
5.10 Medtronic plc Company Overview
5.10.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Smartwave Medical Ltd Company Overview
5.11.1 Smartwave Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Implantable Cardioverter Defibrillators (ICD) - Recent Developments
6.1 May 11, 2018: Boston Scientific Announces Real-World Data Demonstrating Success Of SMART Pass On The S-ICD System
6.2 May 11, 2018: Medtronic Study Confirms Feasibility of New Extravascular Approach to ICD Therapy
6.3 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.4 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018
6.5 Apr 25, 2018: CONMED Announces First Quarter 2018 Financial Results
6.6 Apr 23, 2018: Philips First Quarter Results 2018
6.7 Apr 19, 2018: Philips showcases dedicated radiation oncology workflow solutions spanning image acquisition to treatment planning at ESTRO 2018
6.8 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.9 Apr 03, 2018: Nihon Kohden Announces Change in Representative Director and Director
6.10 Mar 19, 2018: Philips convenes the 2018 Annual General Meeting of Shareholders
6.11 Mar 07, 2018: Philips again ranks first in ‘medical technology’ patents filed at the European Patent Office
6.12 Feb 27, 2018: genedrive Receives Significant Funding for TB Test Development
6.13 Feb 26, 2018: Medtronic Recalls Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillators Due to Manufacturing Error Preventing Electrical Shock Delivery
6.14 Feb 26, 2018: Tissue Regenix Group: Launch of TRX BioSurgery and new distributor agreement
6.15 Feb 20, 2018: Philips increases Green Revenues to EUR 10.7 billion, 60% of total sales in 2017
6.16 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
6.17 Jan 31, 2018: CONMED Announces Fourth Quarter and Fiscal Year 2017 Financial Results
6.18 Jan 30, 2018: Philips' Fourth Quarter and Annual Results 2017
6.19 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.20 Jan 11, 2018: Andover will lose nearly 2,000 jobs with Philips move
6.21 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
6.22 Jan 03, 2018: New FDA MR-Conditional Labeling Approvals Further Expand Abbott's Fortify Assura Implantable Cardioverter Defibrillator
6.23 Jan 02, 2018: CONMED Appoints Todd W. Garner as Executive Vice President and Chief Financial Officer
6.24 Dec 22, 2017: Boston Scientific pacemakers and defibrillators
6.25 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
6.26 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results
6.27 Nov 09, 2017: JMS: Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2018
6.28 Nov 08, 2017: New Societal Guidelines Recommend Subcutaneous Implantable Cardioverter-Defibrillator for Patients with Ventricular Arrhythmias at Risk of Sudden Cardiac Death
6.29 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue
6.30 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report
6.31 Nov 02, 2017: Philips provides update on the company strategy and performance at Capital Markets Day in New York
6.32 Nov 02, 2017: CONMED Announces Retirement of Chief Financial Officer
6.33 Nov 02, 2017: CONMED Announces Third Quarter 2017 Financial Results
6.34 Nov 02, 2017: Nihon Kohden opens a sales branch in Kenya
6.35 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017
6.36 Oct 23, 2017: Philips' Third Quarter Results 2017
6.37 Oct 20, 2017: Extraordinary General Meeting of Shareholders appoints Marnix van Ginneken to Philips’ Board of Management
6.38 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
6.39 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
6.40 Sep 22, 2017: Abbott Secures FDA Approval for MRI-compatibility for the Company's Ellipse ICD
6.41 Sep 18, 2017: Philips Steps Up Commitment to Ensuring Healthy Lives for All During United Nations General Assembly Week
6.42 Aug 24, 2017: Philips appoints Egbert van Acht as Chief Business Leader of the Personal Health businesses, and proposes to appoint Marnix van Ginneken as member of the Board of Management
6.43 Aug 24, 2017: Governor Haslam, Commissioner Rolfe Announce Philips to Establish Business Center of Expertise in Middle Tennessee
6.44 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.45 Aug 09, 2017: JMS: Financial Results for the First Quarter of Fiscal Year Ending March 31, 2018
6.46 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
6.47 Jul 26, 2017: CONMED Announces Second Quarter 2017 Financial Results
6.48 Jul 24, 2017: Philips' Second Quarter Results 2017
6.49 Jul 20, 2017: Chief Business Leader of Philips’ Personal Health businesses Pieter Nota to leave company
6.50 Jul 13, 2017: Nihon Kohden Selected for FTSE4Good Index Series and FTSE Blossom Japan Index
6.51 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
6.52 Jun 13, 2017: Nihon Kohden to reorganize its group companies in India

7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
Table 2: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment
Table 3: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory
Table 4: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path
Table 5: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date
Table 6: Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials
Table 7: Implantable Cardioverter Defibrillators (ICD) Companies - Pipeline Products by Stage of Development
Table 8: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
Table 9: AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Guardian - Product Status
Table 11: Guardian - Product Description
Table 12: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 13: EMBLEM MRI S-ICD System - Aged Patients - Product Status
Table 14: EMBLEM MRI S-ICD System - Aged Patients - Product Description
Table 15: S-ICD System 1.5 - Product Status
Table 16: S-ICD System 1.5 - Product Description
Table 17: S-ICD System 2.0 - Product Status
Table 18: S-ICD System 2.0 - Product Description
Table 19: VITALITY NXT Defibrillator - Product Status
Table 20: VITALITY NXT Defibrillator - Product Description
Table 21: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 22: S-ICD System 2.0 - A Prospective Randomized Comparative Trial of Subcutaneous Implantable Cardioverter-Defibrillator Implantation with and Without Defibrillation Testing
Table 23: S-ICD System 1.5 - A Prospective Randomized Comparative Trial of Subcutaneous Implantable Cardioverter-Defibrillator Implantation with and Without Defibrillation Testing
Table 24: EMBLEM MRI S-ICD System - Aged Patients - Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator: MADIT S-ICD
Table 25: CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 26: CardiaLen Device - Atrial Fibrillation - Product Status
Table 27: CardiaLen Device - Atrial Fibrillation - Product Description
Table 28: CardiaLen Device - Ventricular Arrhythmia - Product Status
Table 29: CardiaLen Device - Ventricular Arrhythmia - Product Description
Table 30: InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 31: PICD - Product Status
Table 32: PICD - Product Description
Table 33: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Cardiac Sock Electrode And Implantable Defibrillator System - Product Status
Table 35: Cardiac Sock Electrode And Implantable Defibrillator System - Product Description
Table 36: Implantable Cardioverter Defibrillator System - Product Status
Table 37: Implantable Cardioverter Defibrillator System - Product Description
Table 38: Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Unconditional MRI Compatible Implantable Defibrillator - Product Status
Table 40: Unconditional MRI Compatible Implantable Defibrillator - Product Description
Table 41: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
Table 42: NAVIGO 4LV 2D - Product Status
Table 43: NAVIGO 4LV 2D - Product Description
Table 44: NAVIGO 4LV ARC - Product Status
Table 45: NAVIGO 4LV ARC - Product Description
Table 46: NAVIGO 4LV PILOT - Product Status
Table 47: NAVIGO 4LV PILOT - Product Description
Table 48: LivaNova PLC - Ongoing Clinical Trials Overview
Table 49: NAVIGO 4LV 2D - Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector
Table 50: NAVIGO 4LV ARC - Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector
Table 51: NAVIGO 4LV PILOT - Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector
Table 52: Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Implantable Cardioverter Defibrillator - Ventricular Arrhythmias - Product Status
Table 54: Implantable Cardioverter Defibrillator - Ventricular Arrhythmias - Product Description
Table 55: Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Implantable Defibrillator - Product Status
Table 57: Implantable Defibrillator - Product Description
Table 58: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Chronicle ICD - Product Status
Table 60: Chronicle ICD - Product Description
Table 61: EV-ICD System - Product Status
Table 62: EV-ICD System - Product Description
Table 63: Smartwave Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Fully Automatic Implantable Atrial Defibrillator - Product Status
Table 65: Fully Automatic Implantable Atrial Defibrillator - Product Description
Table 66: Glossary

List of Figures
Figure 1: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
Figure 2: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment
Figure 3: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory
Figure 4: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path
Figure 5: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date
Figure 6: Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AIS Inc.
  • Boston Scientific Corp
  • CardiaLen Inc.
  • InnerPulse Inc
  • Johns Hopkins University
  • Kenergy Inc.
  • LivaNova PLC
  • Massachusetts General Hospital
  • Max Planck Institute for Dynamics and Self-Organization
  • Medtronic plc
  • Smartwave Medical Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll